Comparative trial of three heterologous anti-tetanus sera.
The three heterologous anti-sera currently provided for tetanus prophylaxis have been compared with reference to the production of untoward reactions in 498 patients, and to the blood antitoxin concentrations produced in 76 patients. Equine serum, although giving rise to more reactions, was the only effective agent in terms of the levels and duration of serum antitoxin concentration produced. The local response to a test dose of any of the three sera is not a reliable guide to immediate or late general reactions.
D000818:Animals; D001168:Arthritis / Q000139:chemically induced; D002417:Cattle; D006736:Horses; D006801:Humans; D008199:Lymphadenitis / Q000139:chemically induced; D012756:Sheep; D012871:Skin Diseases / Q000139:chemically induced; D013742:Tetanus / Q000517:prevention & control; D013743:Tetanus Antitoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D013743:Tetanus Antitoxin